Aethlon Medical
AEMD
Aethlon Medical (AEMD) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Neutral | $1.50 | Aug 14, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Neutral | $1.50 | Jul 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Mar 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Feb 19, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jan 30, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Nov 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $10.00 | Jun 24, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $23.00 | Mar 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $23.00 from $90.00 | Oct 24, 2023 |
Frequently asked questions
What is the latest analyst rating on AEMD?
On Aug 14, 2025, HC Wainwright & Co. maintained Aethlon Medical at Neutral with a price target of $1.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.